Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

ASVM van den Heerik, N Horeweg… - International Journal of …, 2021 - ijgc.bmj.com
Endometrial cancer is primarily treated with surgery. Adjuvant treatment strategies for
endometrial cancer, such as external beam pelvic radiotherapy, vaginal brachytherapy …

Optimal treatment in locally advanced cervical cancer

C Gennigens, M De Cuypere, J Hermesse… - Expert Review of …, 2021 - Taylor & Francis
Introduction: Locally advanced cervical cancer (LACC)(International Federation of
Gynecology and Obstetrics (FIGO) 2009/2018–stages IB2-IVA/IB3-IVA, respectively) is …

Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial

S Chopra, S Gupta, S Kannan, T Dora… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III
randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy …

Radiation therapy for endometrial cancer: an American society for radiation oncology clinical practice guideline

MM Harkenrider, N Abu-Rustum, K Albuquerque… - Practical radiation …, 2023 - Elsevier
Purpose With the results of several recently published clinical trials, this guideline informs on
the use of adjuvant radiation therapy (RT) and systemic therapy in the treatment of …

Identifying patients whose symptoms are underrecognized during treatment with breast radiotherapy

R Jagsi, KA Griffith, F Vicini, T Boike… - JAMA …, 2022 - jamanetwork.com
Importance Understanding whether physicians accurately detect symptoms in patients with
breast cancer is important because recognition of symptoms facilitates supportive care, and …

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

C Chargari, K Tanderup, F Planchamp, L Chiva… - Radiotherapy and …, 2023 - Elsevier
Abstract Background The European Society of Gynaecological Oncology (ESGO) has
previously defined and established a list of quality indicators for the surgical treatment of …

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

LR Duska, JM Scalici, SM Temkin, JK Schwarz… - Cancer, 2020 - Wiley Online Library
Background Immune checkpoint inhibitors are being considered for locally advanced
cervical cancer (LACC) together with standard‐of‐care pelvic chemoradiation (CRT) …

Updates in the treatment of vaginal cancer

A Jhingran - International Journal of Gynecologic Cancer, 2022 - ijgc.bmj.com
Vaginal cancer is a rare cancer. A lot of the data used in the treatment of this cancer are
extrapolated from cervical cancer data. Radiation therapy plays a significant role in the …

[HTML][HTML] Untold story of human cervical cancers: HPV-negative cervical cancer

JE Lee, Y Chung, S Rhee, TH Kim - BMB reports, 2022 - ncbi.nlm.nih.gov
Cervical cancer is the fourth most common malignancy in women worldwide. Although
infection from human papillomavirus (HPV) has been the leading cause of cervical cancer …

[HTML][HTML] Implementing cone-beam computed tomography-guided online adaptive radiotherapy in cervical cancer

CE Shelley, MA Bolt, R Hollingdale… - Clinical and …, 2023 - Elsevier
Background and purpose Adaptive radiotherapy (ART) in locally advanced cervical cancer
(LACC) has shown promising outcomes. This study investigated the feasibility of cone-beam …